<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Idris F</submitter><funding>PMO | National Research Foundation Singapore (NRF)</funding><funding>MOH | National Medical Research Council (NMRC)</funding><pagination>2995-3020</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12603335</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>17(11)</volume><pubmed_abstract>Non-structural protein 1 (NS1) of dengue virus (DENV) harbours two conserved N-glycosylation sites at positions 130 and 207, whose biological roles have remained elusive. Using a clinically relevant mouse model of severe dengue, we showed that DENV that lacked N207 glycans on NS1 was significantly attenuated, and this phenotype was dominant over wild-type virulent DENV. Mice infected with this mutant exhibited accelerated viral clearance, milder lymphopenia and more functional DENV-specific CD8&lt;sup>+&lt;/sup> T cells. Bulk and single-cell RNA sequencing, cytokine measurements and immune-phenotyping revealed blunted innate inflammatory responses early post-infection, which correlated with reduced PD-L1 expression on innate immune cells and reduced PD-1&lt;sup>+&lt;/sup> T-cells in mice infected with</pubmed_abstract><journal>EMBO molecular medicine</journal><pubmed_title>Glycans on non-structural protein 1 prevent premature T-cell mediated dengue virus clearance.</pubmed_title><pmcid>PMC12603335</pmcid><funding_grant_id>MOH-000087</funding_grant_id><funding_grant_id>NRF-CRP27-2021-0003</funding_grant_id><pubmed_authors>Copping JM</pubmed_authors><pubmed_authors>Alonso S</pubmed_authors><pubmed_authors>Allison JR</pubmed_authors><pubmed_authors>Idris F</pubmed_authors><pubmed_authors>Tan ETX</pubmed_authors><pubmed_authors>Li QH</pubmed_authors><pubmed_authors>Ooi JSG</pubmed_authors><pubmed_authors>Walsh I</pubmed_authors><pubmed_authors>Ng LY</pubmed_authors><pubmed_authors>Wan C</pubmed_authors><pubmed_authors>Marzinek JK</pubmed_authors><pubmed_authors>Bond PJ</pubmed_authors><pubmed_authors>Chan KR</pubmed_authors><pubmed_authors>Torta F</pubmed_authors><pubmed_authors>Lim SY</pubmed_authors><pubmed_authors>Nguyen-Khuong T</pubmed_authors><pubmed_authors>Ting DHR</pubmed_authors><pubmed_authors>Benke PI</pubmed_authors></additional><is_claimable>false</is_claimable><name>Glycans on non-structural protein 1 prevent premature T-cell mediated dengue virus clearance.</name><description>Non-structural protein 1 (NS1) of dengue virus (DENV) harbours two conserved N-glycosylation sites at positions 130 and 207, whose biological roles have remained elusive. Using a clinically relevant mouse model of severe dengue, we showed that DENV that lacked N207 glycans on NS1 was significantly attenuated, and this phenotype was dominant over wild-type virulent DENV. Mice infected with this mutant exhibited accelerated viral clearance, milder lymphopenia and more functional DENV-specific CD8&lt;sup>+&lt;/sup> T cells. Bulk and single-cell RNA sequencing, cytokine measurements and immune-phenotyping revealed blunted innate inflammatory responses early post-infection, which correlated with reduced PD-L1 expression on innate immune cells and reduced PD-1&lt;sup>+&lt;/sup> T-cells in mice infected with</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Nov</publication><modification>2026-06-06T15:45:20.495Z</modification><creation>2026-06-02T03:09:20.855Z</creation></dates><accession>S-EPMC12603335</accession><cross_references><pubmed>40962941</pubmed><doi>10.1038/s44321-025-00311-6</doi></cross_references></HashMap>